Agilera Pharma AS and Radiopharmacy
Agilera’s vision is to realise the cancer medicine of tomorrow. We work closely with our partners to take new, innovative radiopharmaceuticals from concept to patient.
Agilera is a leading contract development and manufacturing organisation (CDMO). With several decades of experience in the production and distribution of radiopharmaceuticals. The Institute for Energy Technology (IFE) established Agilera as daughter company in 2023.
Agilera provides expertise and infrastructure that makes it possible to bring new, innovative radiopharmaceuticals from concept to clinic and onward to commercialisation. In close collaboration with our clients, we will realise the cancer medicine of tomorrow.